“`html
Pulsed Field Ablation Shows Long-Term Promise for Atrial Fibrillation Treatment
Published: 2026/02/07 23:34:46
Atrial fibrillation (AFib), a common heart rhythm disorder, affects millions worldwide. Traditional treatments often involve ablation – the destruction of heart tissue causing irregular beats. Now, a newer technique called pulsed field ablation (PFA) is demonstrating sustained effectiveness and potential advantages over conventional thermal ablation methods. Recent data from the ADVENT-LTO study,a long-term follow-up of the groundbreaking ADVENT trial,reinforces PFA’s position as a promising treatment option.
Understanding Atrial Fibrillation and Ablation
Atrial fibrillation occurs when the upper chambers of the heart (atria) beat irregularly and too quickly.This can lead to symptoms like palpitations, shortness of breath, and fatigue, and increases the risk of stroke. Cardiac ablation aims to eliminate the abnormal electrical signals causing AFib, restoring a normal heart rhythm.
Thermal ablation, the traditional method, uses heat to destroy the problematic heart tissue. While effective, it carries risks of collateral damage to surrounding structures. PFA, though, utilizes short bursts of electrical energy to selectively target and ablate heart tissue, minimizing the risk of thermal injury.
The ADVENT-LTO Study: Four-Year Results
The ADVENT-LTO study followed 364 patients with paroxysmal AFib (afib that comes and goes) for an average of 1,332 days. Participants were randomly assigned to receive either PFA or conventional thermal ablation. The study focused on evaluating treatment success after four years.
The results showed that PFA maintained a high level of effectiveness comparable to thermal ablation, with a four-year treatment success rate of 72.8% for PFA versus 64.1% for thermal ablation (P=0.12). Moreover, the study revealed several trends favoring PFA:
- Reduced Need for Repeat Procedures: Patients treated with PFA experienced fewer repeat ablations (10.4%) compared to those receiving thermal ablation (17.7%) (P=0.04).
- Lower Risk of Arrhythmia Intervention: PFA was associated with a lower rate of hospital-based arrhythmia intervention (85.6% PFA vs. 78.6% thermal; HR 0.64, 95%CI 0.38, 1.05).
- Potential for Preventing Persistent AFib: There was a trend towards a lower rate of progression to persistent AFib (continuous AFib) in the PFA group (2.6%) compared to the
Related reading